Arkolith/Insider Trading/FIXX/Form 4

Tzianabos Arthur

DirectorHomology Medicines, Inc. (FIXX) · full profile →Form 4 · filed Feb 15, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2024Sell(S)13K$0.57$7K129K
Jan 1, 2024Option exercise(M)19K——142K
Jan 1, 2024Option exercise(M)14K——123K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 1, 2024Option exercise(M)19K—$020K
Jan 1, 2024Option exercise(M)14K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-015944) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML